◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

LSL Pharma Group Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Total Revenue 7.6M 7.2M 6.6M 5.4M 4.0M
Operating Revenue 7.6M 7.2M 6.6M 5.4M 4.0M
Cost Of Revenue 5.2M 5.2M 4.5M 3.9M 2.8M
Gross Profit 2.3M 2.1M 2.1M 1.5M 1.2M
Selling General And Administration 1.8M 1.5M 1.6M 1.2M 1.1M
General And Administrative Expense 1.8M 1.5M 1.6M 1.2M 1.1M
Research And Development -- -- -- -- --
Depreciation And Amortization In Income Statement 142,000 230,000 35,000 81,000 35,000
Operating Expense 1.9M 1.8M 1.7M 1.3M 1.1M
Operating Income 394,000 304,000 433,000 216,000 85,000
EBIT -422,000 222,000 365,000 5.1M 15,000
Interest Expense 758,000 611,000 520,000 517,000 401,000
Interest Expense Non Operating 758,000 611,000 520,000 517,000 401,000
Net Interest Income -817,000 -693,000 -588,000 -552,000 -478,000
Other Income Expense -757,000 -- -- 4.9M 7,000
Special Income Charges -757,000 0.00 -- 4.9M 7,000
Restructuring And Mergern Acquisition 0.00 0.00 -- -4.9M -7,000
Pretax Income -1.2M -389,000 -155,000 4.5M -386,000
Tax Provision -- -- -- -- --
Tax Effect Of Unusual Items 0.00 0.00 0.00 732,750 0.00
Net Income From Continuing And Discontinued Operation -1.2M -389,000 -155,000 4.5M -386,000
Net Income From Continuing Operation Net Minority Interest -1.2M -389,000 -155,000 4.5M -386,000
Net Income Including Noncontrolling Interests -1.2M -389,000 -155,000 4.5M -386,000
Net Income Common Stockholders -1.2M -389,000 -155,000 4.5M -386,000
Net Income -1.2M -389,000 -155,000 4.5M -386,000
EBITDA 184,000 929,000 836,000 5.5M 369,000
Normalized EBITDA 941,000 929,000 836,000 656,000 362,000
Reconciled Depreciation 606,000 707,000 471,000 475,000 354,000
Basic EPS -0.01 0.00 0.00 -- 0.00
Diluted EPS -0.01 0.00 0.00 -- 0.00
Basic Average Shares 117.6M 115.5M 115.5M -- 115.1M
Diluted Average Shares 117.6M 115.5M 115.5M -- 115.3M
Total Unusual Items -757,000 0.00 -- 4.9M 7,000
Total Unusual Items Excluding Goodwill -757,000 0.00 -- 4.9M 7,000
Tax Rate For Calcs 0.00 0.00 0.00 0.15 0.00
Normalized Income -423,000 -389,000 -155,000 346,750 -393,000
Depreciation Amortization Depletion Income Statement 142,000 230,000 35,000 81,000 35,000
Depreciation Income Statement -- 230,000 -- -- 35,000
Diluted NI Availto Com Stockholders -1.2M -389,000 -155,000 4.5M -386,000
Net Income Continuous Operations -1.2M -389,000 -155,000 4.5M -386,000
Net Non Operating Interest Income Expense -817,000 -693,000 -588,000 -552,000 -478,000
Other Gand A 779,000 810,000 836,000 353,000 568,000
Other Special Charges 757,000 -- -- -- --
Reconciled Cost Of Revenue 4.8M 4.7M 4.1M 3.5M 2.5M
Salaries And Wages 1.0M 717,000 802,000 822,000 506,000
Selling And Marketing Expense -- -- -- -- --
Total Expenses 7.2M 6.9M 6.2M 5.2M 3.9M
Total Operating Income As Reported 482,000 340,000 447,000 300,000 85,000
Total Other Finance Cost 59,000 82,000 68,000 35,000 77,000
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Cash And Cash Equivalents 449,000 201,000 177,000 296,000 164,000
Cash Cash Equivalents And Short Term Investments 449,000 201,000 177,000 296,000 164,000
Accounts Receivable 5.9M 5.2M 5.2M 4.8M 3.4M
Receivables 5.9M 5.2M 5.2M 5.0M 3.4M
Inventory 13.4M 12.4M 11.7M 9.1M 5.6M
Prepaid Assets 920,000 664,000 610,000 1.0M 688,000
Current Assets 20.7M 23.2M 17.7M 15.4M 9.9M
Gross PPE -- -- -- 26.7M --
Accumulated Depreciation -- -- -- -3.7M --
Net PPE 24.8M 24.4M 22.9M 22.9M 18.9M
Goodwill 157,000 157,000 157,000 157,000 --
Goodwill And Other Intangible Assets 14.5M 13.9M 13.6M 13.4M 9.1M
Other Intangible Assets 14.3M 13.8M 13.4M 13.3M --
Total Non Current Assets 39.5M 38.6M 38.3M 38.1M 28.1M
Total Assets 60.2M 61.8M 56.0M 53.5M 38.0M
Current Debt 8.9M 10.2M 4.9M 4.0M 4.7M
Current Debt And Capital Lease Obligation 9.4M 10.6M 5.4M 4.5M 5.0M
Accounts Payable -- -- -- 4.5M --
Payables -- -- -- 4.5M --
Payables And Accrued Expenses 4.1M 7.5M 6.3M 5.2M 3.5M
Current Accrued Expenses -- -- -- 655,000 --
Current Liabilities 13.5M 18.1M 11.7M 9.7M 8.5M
Long Term Debt 15.4M 13.3M 13.4M 12.8M 6.5M
Long Term Debt And Capital Lease Obligation 19.5M 17.5M 17.7M 17.2M 9.1M
Long Term Capital Lease Obligation 4.1M 4.2M 4.3M 4.4M 2.6M
Total Non Current Liabilities Net Minority Interest 21.3M 19.3M 19.5M 19.0M 9.1M
Total Liabilities Net Minority Interest 34.8M 37.4M 31.2M 28.6M 17.6M
Common Stock 38.5M 36.4M 36.4M 36.4M 36.7M
Capital Stock 38.5M 36.4M 36.4M 36.4M 36.7M
Additional Paid In Capital 3.6M 3.1M 3.1M 3.0M 2.7M
Retained Earnings -16.6M -15.5M -15.1M -14.9M -19.4M
Common Stock Equity 25.4M 24.4M 24.8M 24.9M 20.4M
Stockholders Equity 25.4M 24.4M 24.8M 24.9M 20.4M
Total Equity Gross Minority Interest 25.4M 24.4M 24.8M 24.9M 20.4M
Total Capitalization 40.8M 37.7M 38.2M 37.6M 26.9M
Net Tangible Assets 10.9M 10.5M 11.2M 11.5M 11.2M
Tangible Book Value 10.9M 10.5M 11.2M 11.5M 11.2M
Working Capital 7.1M 5.1M 6.0M 5.7M 1.4M
Invested Capital 49.7M 47.8M 43.1M 41.7M 31.6M
Total Debt 28.9M 28.1M 23.1M 21.6M 14.0M
Net Debt 23.9M 23.2M 18.2M 16.5M 11.0M
Share Issued 121.2M 115.5M 115.5M 115.5M 115.5M
Ordinary Shares Number 121.2M 115.5M 115.5M 115.5M 115.5M
Allowance For Doubtful Accounts Receivable -- -- -- -7,000 --
Buildings And Improvements -- -- -- 10.7M --
Capital Lease Obligations 4.5M 4.7M 4.8M 4.9M 2.8M
Construction In Progress -- -- -- 0.00 --
Current Capital Lease Obligation 484,000 473,000 462,000 447,000 263,000
Current Notes Payable 1.2M -- -- -- 0.00
Finished Goods -- -- -- 3.7M --
Gross Accounts Receivable -- -- -- 4.8M --
Interest Payable -- -- -- 237,000 --
Inventories Adjustments Allowances -- -- -- -166,000 --
Land And Improvements -- -- -- 556,000 --
Line Of Credit 6.8M 8.2M 3.1M 2.6M 514,000
Machinery Furniture Equipment -- -- -- 614,000 --
Non Current Deferred Assets 223,000 223,000 223,000 223,000 --
Non Current Deferred Liabilities 1.8M 1.8M 1.8M 1.8M 33,000
Non Current Deferred Taxes Assets 223,000 223,000 223,000 223,000 --
Non Current Deferred Taxes Liabilities 1.8M 1.8M 1.8M 1.8M 33,000
Non Current Prepaid Assets 74,000 60,000 1.5M 1.5M 20,000
Other Current Borrowings 897,000 1.9M 1.8M 1.5M 4.2M
Other Equity Interest -- 375,000 375,000 375,000 375,000
Other Inventories -- -- -- 989,000 --
Other Properties -- -- -- 14.8M --
Properties -- -- -- 0.00 --
Raw Materials -- -- -- 4.0M --
Restricted Cash -- 4.8M -- -- --
Taxes Receivable 9,000 9,000 9,000 154,000 --
Total Tax Payable -- -- -- 37,000 --
Work In Process -- -- -- 541,000 --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Operating Cash Flow -4.4M 1.5M -483,000 452,000 -87,000
Cash Flow From Continuing Operating Activities -4.4M 1.5M -483,000 452,000 -87,000
Depreciation And Amortization 606,000 707,000 471,000 475,000 354,000
Depreciation Amortization Depletion 606,000 707,000 471,000 475,000 354,000
Stock Based Compensation 88,000 36,000 14,000 16,000 0.00
Change In Working Capital -5.5M 440,000 -1.4M -323,000 -526,000
Changes In Account Receivables -685,000 27,000 -279,000 124,000 -125,000
Change In Receivables -685,000 27,000 -279,000 124,000 -125,000
Change In Inventory -915,000 -703,000 -2.6M -555,000 -317,000
Change In Payables And Accrued Expense -3.7M 1.2M 1.0M 245,000 -411,000
Other Non Cash Items 817,000 693,000 588,000 -4.3M 478,000
Capital Expenditure -1.6M -985,000 -636,000 -1.0M -1.4M
Purchase Of PPE -849,000 -440,000 -374,000 -453,000 -1.2M
Net PPE Purchase And Sale -849,000 -440,000 -374,000 -453,000 -1.2M
Purchase Of Business 0.00 0.00 -- -1.1M -30,000
Investing Cash Flow -1.6M -985,000 -636,000 -2.1M -1.4M
Cash Flow From Continuing Investing Activities -1.6M -985,000 -636,000 -2.1M -1.4M
Issuance Of Debt 8.4M 500,000 1.9M 6.2M 1.7M
Repayment Of Debt -6.7M -671,000 -540,000 -4.0M -731,000
Net Issuance Payments Of Debt 196,000 5.0M 1.4M 2.6M 798,000
Issuance Of Capital Stock 2.3M 0.00 0.00 0.00 960,000
Net Common Stock Issuance 2.3M 0.00 0.00 0.00 960,000
Financing Cash Flow 1.5M 4.3M 1.0M 1.8M 1.4M
Cash Flow From Continuing Financing Activities 1.5M 4.3M 1.0M 1.8M 1.4M
Changes In Cash -4.5M 4.8M -119,000 132,000 -125,000
Beginning Cash Position 5.0M 177,000 296,000 164,000 289,000
End Cash Position 449,000 5.0M 177,000 296,000 164,000
Free Cash Flow -6.0M 502,000 -1.1M -565,000 -1.4M
Cash Dividends Paid 0.00 0.00 0.00 0.00 0.00
Change In Prepaid Assets -250,000 -61,000 397,000 -137,000 327,000
Common Stock Issuance 2.3M 0.00 0.00 0.00 960,000
Gain Loss On Sale Of Business 0.00 -- -- -- -7,000
Interest Paid Cff -590,000 -593,000 -363,000 -691,000 -155,000
Long Term Debt Issuance 8.4M 500,000 598,000 5.8M 1.7M
Long Term Debt Payments -6.7M -671,000 -540,000 -4.0M -731,000
Net Business Purchase And Sale 0.00 0.00 -- -1.1M -30,000
Net Income From Continuing Operations -1.2M -389,000 -155,000 4.5M -386,000
Net Intangibles Purchase And Sale -715,000 -545,000 -262,000 -564,000 -167,000
Net Long Term Debt Issuance 1.6M -171,000 58,000 1.8M 963,000
Net Other Financing Charges -417,000 -74,000 -- -89,000 -248,000
Net Short Term Debt Issuance -1.5M 5.1M 1.3M 785,000 -165,000
Operating Gains Losses 757,000 -- -- -- -7,000
Purchase Of Intangibles -715,000 -545,000 -262,000 -564,000 -167,000
Short Term Debt Issuance -- -- 1.3M -- --
NEWS
Loading news...
TRENDING
Loading...